EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Imaging Methods Applicable in the Diagnostics of Alzheimer’s Disease, Considering the Involvement of Insulin Resistance

Petra Hnilicova iD, Ema Kantorova, Stanislav Sutovsky, Milan Grofik, Kamil Zelenak iD, Egon Kurca, Norbert Zilka, Petra Parvanovova, Martin Kolisek

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043325 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Petra Hnilicova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia. Hauptthemen laut MEDLINE: Alzheimer Disease, Insulin Resistance, Neurodegenerative Diseases, Insulins. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovak Research and Development Agency, The Ministry of Education, Science, Research and Sport of the Slovak Republic, The Slovak Research and Development Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is an incurable neurodegenerative disease and the most frequently diagnosed type of dementia, characterized by (1) perturbed cerebral perfusion, vasculature, and cortical metabolism; (2) induced proinflammatory processes; and (3) the aggregation of amyloid beta and hyperphosphorylated Tau proteins. Subclinical AD changes are commonly detectable by using radiological and nuclear neuroimaging methods such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and single-photon emission computed tomography (SPECT). Furthermore, other valuable modalities exist (in particular, structural volumetric, diffusion, perfusion, functional, and metabolic magnetic resonance methods) that can advance the diagnostic algorithm of AD and our understanding of its pathogenesis. Recently, new insights into AD pathoetiology revealed that deranged insulin homeostasis in the brain may play a role in the onset and progression of the disease. AD-related brain insulin resistance is closely linked to systemic insulin homeostasis disorders caused by pancreas and/or liver dysfunction. Indeed, in recent studies, linkages between the development and onset of AD and the liver and/or pancreas have been established. Aside from standard radiological and nuclear neuroimaging methods and clinically fewer common methods of magnetic resonance, this article also discusses the use of new suggestive non-neuronal imaging modalities to assess AD-associated structural changes in the liver and pancreas. Studying these changes might be of great clinical importance because of their possible involvement in AD pathogenesis during the prodromal phase of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseInsulin ResistanceNeurodegenerative DiseasesInsulinsHumansAmyloid beta-PeptidesPositron-Emission TomographyNeuroimagingMagnetic Resonance ImagingBrain

Stichwörter der Autor:innen

Alzheimer’s diseasediffusion magnetic resonancefunctional magnetic resonanceinsulin resistancelivermagnetic resonance spectroscopymagnetic resonance volumetryneuroimagingpancreasperfusion magnetic resonancepositron emission tomography

Substanzen

Amyloid beta-PeptidesInsulins

Autor:innen und Institutionen

  • Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.
  • Clinic of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.
  • 1st Department of Neurology, Faculty of Medicine, Comenius University in Bratislava and University Hospital, 813 67 Bratislava, Slovakia.
  • Clinic of Radiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.
  • Institute of Neuroimmunology, Slovak Academy of Sciences, 845 10 Bratislava, Slovakia.
  • Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.

ORCID-Profile: Petra Hnilicova, Kamil Zelenak

Förderung

  • Slovak Research and Development Agency
  • The Ministry of Education, Science, Research and Sport of the Slovak Republic
  • The Slovak Research and Development Agency

Zitieren

APA

Hnilicova, P., Kantorova, E., Sutovsky, S., Grofik, M., Zelenak, K., Kurca, E., Zilka, N., Parvanovova, P., & Kolisek, M. (2023). Imaging Methods Applicable in the Diagnostics of Alzheimer’s Disease, Considering the Involvement of Insulin Resistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043325

Vancouver

Hnilicova P, Kantorova E, Sutovsky S, Grofik M, Zelenak K, Kurca E, et al. Imaging Methods Applicable in the Diagnostics of Alzheimer’s Disease, Considering the Involvement of Insulin Resistance. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043325

BibTeX
@article{Hnilicova2023,
  author = {Hnilicova, Petra and Kantorova, Ema and Sutovsky, Stanislav and Grofik, Milan and Zelenak, Kamil and Kurca, Egon and Zilka, Norbert and Parvanovova, Petra and Kolisek, Martin},
  title = {Imaging Methods Applicable in the Diagnostics of Alzheimer’s Disease, Considering the Involvement of Insulin Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043325}
}
Kostenlos starten →